Literature DB >> 26401080

Efficiency and safety of radiofrequency-assisted hepatectomy for hepatocellular carcinoma with cirrhosis: A single-center retrospective cohort study.

Fan Zhang1, Jun Yan1, Xiao-Bin Feng1, Feng Xia1, Xiao-Wu Li1, Kuan-Sheng Ma1, Ping Bie1.   

Abstract

AIM: To assess the efficiency and safety of radiofrequency-assisted hepatectomy in patients with hepatocellular carcinoma (HCC) and cirrhosis.
METHODS: From January 2010 to December 2013, 179 patients with HCC and cirrhosis were recruited for this retrospective study. Of these, 100 patients who received radiofrequency-assisted hepatectomy (RF+ group) were compared to 79 patients who had hepatectomy without ablation (RF- group). The primary endpoint was intraoperative blood loss. The secondary endpoints included liver function, postoperative complications, mortality, and duration of hospital stay.
RESULTS: The characteristics of the two groups were closely matched. The Pringle maneuver was not used in the RF+ group. There was significantly less median intraoperative blood loss in the RF+ group (300 vs 400 mL, P = 0.01). On postoperative days (POD) 1 and 5, median alanine aminotransferase was significantly higher in the RF+ group than in the RF- group (POD 1: 348.5 vs 245.5, P = 0.01; POD 5: 112 vs 82.5, P = 0.00), but there was no significant difference between the two groups on POD 3 (260 vs 220, P = 0.24). The median AST was significantly higher in the RF+ group on POD 1 (446 vs 268, P = 0.00), but there was no significant difference between the two groups on POD 3 and 5 (POD 3: 129.5 vs 125, P = 0.65; POD 5: 52.5 vs 50, P = 0.10). Overall, the rate of postoperative complications was roughly the same in these two groups (28.0% vs 17.7%, P = 0.11) except that post hepatectomy liver failure was far more common in the RF+ group than in the RF- group (6% vs 0%, P = 0.04).
CONCLUSION: Radiofrequency-assisted hepatectomy can reduce intraoperative blood loss during liver resection effectively. However, this method should be used with caution in patients with concomitant cirrhosis because it may cause severe liver damage and liver failure.

Entities:  

Keywords:  Blood loss; Cirrhosis; Complications; Hepatocellular carcinoma; Radiofrequency-assisted hepatectomy

Mesh:

Year:  2015        PMID: 26401080      PMCID: PMC4572796          DOI: 10.3748/wjg.v21.i35.10159

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Randomized clinical trial of radiofrequency-assisted versus clamp-crushing liver resection.

Authors:  L Lupo; A Gallerani; P Panzera; F Tandoi; G Di Palma; V Memeo
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

2.  The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy.

Authors:  Silvio Balzan; Jacques Belghiti; Olivier Farges; Satoshi Ogata; Alain Sauvanet; Didier Delefosse; François Durand
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

3.  Is there any benefit from expanding the criteria for the resection of hepatocellular carcinoma in cirrhotic liver? Experience from a developing country.

Authors:  Danijel A Galun; Predrag Bulajic; Marinko Zuvela; Dragan Basaric; Tatjana Ille; Miroslav N Milicevic
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

Review 4.  Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update.

Authors:  Marco Vivarelli; Roberto Montalti; Andrea Risaliti
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 5.  Current role of bloodless liver resection.

Authors:  Spiros G Delis; Juan Madariaga; A Bakoyiannis; Ch Dervenis
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

Review 6.  The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.

Authors:  Stephen Caldwell; Sang H Park
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

7.  Radiofrequency-assisted liver resection in cirrhotic patients with hepatocellular carcinoma.

Authors:  Giuseppe Curro; Long Jiao; Claudio Scisca; Umberto Baccarani; Massimo Mucciardi; Nagy Habib; Giuseppe Navarra
Journal:  J Surg Oncol       Date:  2008-11-01       Impact factor: 3.454

8.  Liver resection with a new multiprobe bipolar radiofrequency device.

Authors:  Ahmet Ayav; Long Jiao; Robert Dickinson; Joanna Nicholls; Miroslav Milicevic; Ricardo Pellicci; Philippe Bachellier; Nagy Habib
Journal:  Arch Surg       Date:  2008-04

9.  Surgical resection of hepatocellular carcinoma.

Authors:  John P Duffy; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Cancer J       Date:  2008 Mar-Apr       Impact factor: 3.360

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  3 in total

1.  Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study.

Authors:  Junhao Zheng; Xu Feng; Yuelong Liang; Jingwei Cai; Zhaoqi Shi; Mubarak Ali Kirih; Liye Tao; Xiao Liang
Journal:  Surg Endosc       Date:  2020-07-06       Impact factor: 4.584

Review 2.  Management of centrally located hepatocellular carcinoma: Update 2016.

Authors:  Wei-Bo Yu; Andrew Rao; Victor Vu; Lily Xu; Jian-Yu Rao; Jian-Xiong Wu
Journal:  World J Hepatol       Date:  2017-05-08

Review 3.  A Systematic Review and Meta-Analysis Comparing Liver Resection with the Rf-Based Device Habib™-4X with the Clamp-Crush Technique.

Authors:  Kumar Jayant; Mikael H Sodergren; Isabella Reccia; Tomokazu Kusano; Dimitris Zacharoulis; Duncan Spalding; Madhava Pai; Long R Jiao; Kai Wen Huang
Journal:  Cancers (Basel)       Date:  2018-11-08       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.